Table 2.

Predicted Mean Costs and Outcomes

Variable	25-Weeks				78-Weeks
	XRNTX	TAU	Diff (SE)	P-value	XRNTX	TAU	Diff (SE)	P-value
Costs
Study-provided XR-NTX therapy - public price	3,247	0	3,247 (546)	<0.001	3,247	0	3,247 (546)	<0.001
Non-study opioid-use-disorder therapy	460	721	−261 (336)	0.44	1,249	1,580	−331 (346)	0.34
Other non-study medical cost	1,060	1,235	−175 (133)	0.19	2,036	2,293	−257 (224)	0.25
Criminal justice	888	456	432 (277)	0.12	1,858	2,225	−367 (882)	0.68
Total Costs	5,655	2,412	3,243 (703)	<0.001	8,390	6,098	2,292 (1,081)	0.03
Outcomes
QALYsa	0.90	0.86	0.04 (0.02)	0.02	0.83	0.81	0.02 (0.02)	0.25
Abstinent Yearsa	0.87	0.74	0.14 (0.03)	<0.001	0.85	0.76	0.09 (0.03)	0.004

^aAnnualized